Key Highlights
- Renée Galá appointed to Dexcom’s Board of Directors, effective March 6, 2025.
- Brings extensive financial, strategic, and operational leadership experience in the life sciences sector.
- Currently serves as President & COO at Jazz Pharmaceuticals, overseeing global business operations.
- Strong track record in financial leadership, international expansion, and business development at high-growth companies.
Source: Business Wire
Notable Quote
“We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey.” – Kevin Sayer, Chairman, President & CEO at Dexcom
Why This Matters
“We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey.” – Kevin Sayer, Chairman, President & CEO at Dexcom
